Efficacy News and Research

RSS
FDA provides guidance on applying for orphan drug designation

FDA provides guidance on applying for orphan drug designation

AstraZeneca signs definitive agreement to acquire Novexel

AstraZeneca signs definitive agreement to acquire Novexel

New energy receptor theory of brain function

New energy receptor theory of brain function

Merck discontinues MK-1903 niacin receptor agonist development program with Arena Pharmaceuticals

Merck discontinues MK-1903 niacin receptor agonist development program with Arena Pharmaceuticals

Positive results from Alimera Sciences' Iluvien FAME trial for DME

Positive results from Alimera Sciences' Iluvien FAME trial for DME

RPC declares 2010 business plans

RPC declares 2010 business plans

Embryo biopsy safe for singleton pregnancies

Embryo biopsy safe for singleton pregnancies

ARCA biopharma submits Gencaro trial protocol for review under the FDA’s SPA process

ARCA biopharma submits Gencaro trial protocol for review under the FDA’s SPA process

Eritoran well tolerated in Phase II trial for severe sepsis

Eritoran well tolerated in Phase II trial for severe sepsis

Arena Pharmaceuticals submits lorcaserin NDA to the FDA

Arena Pharmaceuticals submits lorcaserin NDA to the FDA

Matrix Laboratories receives FDA tentative approval for Efavirenz NDA under PEPFAR

Matrix Laboratories receives FDA tentative approval for Efavirenz NDA under PEPFAR

Web-based CME courses to educate physicians on drug industry offered by FSMB Foundation

Web-based CME courses to educate physicians on drug industry offered by FSMB Foundation

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

School intervention programs may promote psychological well-being among adolescents

School intervention programs may promote psychological well-being among adolescents

Revel Consulting launches Healthcare Practice to improve healthcare quality

Revel Consulting launches Healthcare Practice to improve healthcare quality

MAA for naproxcinod submitted to EMEA through centralized procedure

MAA for naproxcinod submitted to EMEA through centralized procedure

Grant of $1 million awarded to develop new treatments for dyskinesia

Grant of $1 million awarded to develop new treatments for dyskinesia

LEO Pharma announces positive results for two Phase III AK clinical trials

LEO Pharma announces positive results for two Phase III AK clinical trials

Effectiveness of VSEL stem cells in regenerative medicine demonstrated at the ASH meeting

Effectiveness of VSEL stem cells in regenerative medicine demonstrated at the ASH meeting

CSC completes a Series B financing round

CSC completes a Series B financing round

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.